Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
    • Abstract:
      Background: Coronavirus Disease-2019 (COVID-19) pandemic has become a major health event that endangers people health throughout China and the world. Understanding the factors associated with COVID-19 disease severity could support the early identification of patients with high risk for disease progression, inform prevention and control activities, and potentially reduce mortality. This study aims to describe the characteristics of patients with COVID-19 and factors associated with severe or critically ill presentation in Jiangsu province, China.
      Methods: Multicentre retrospective cohort study of all individuals with confirmed Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infections diagnosed at 24 COVID-19-designated hospitals in Jiangsu province between the 10th January and 15th March 2020. Demographic, clinical, laboratory, and radiological data were collected at hospital admission and data on disease severity were collected during follow-up. Patients were categorised as asymptomatic/mild/moderate, and severe/critically ill according to the worst level of COVID-19 recorded during hospitalisation.
      Results: A total of 625 patients, 64 (10.2%) were severe/critically ill and 561 (89.8%) were asymptomatic/mild/moderate. All patients were discharged and no patients died. Patients with severe/critically ill COVID-19 were more likely to be older, to be single onset (i.e. not belong to a cluster of cases in a family/community, etc.), to have a medical history of hypertension and diabetes; had higher temperature, faster respiratory rates, lower peripheral capillary oxygen saturation (SpO 2 ), and higher computer tomography (CT) image quadrant scores and pulmonary opacity percentage; had increased C-reactive protein, fibrinogen, and D-dimer on admission; and had lower white blood cells, lymphocyte, and platelet counts and albumin on admission than asymptomatic/mild/moderate cases. Multivariable regression showed that odds of being a severe/critically ill case were associated with age (year) (OR 1.06, 95%CI 1.03-1.09), lymphocyte count (10 9 /L) (OR 0.25, 95%CI 0.08-0.74), and pulmonary opacity in CT (per 5%) on admission (OR 1.31, 95%CI 1.15-1.51).
      Conclusions: Severe or critically ill patients with COVID-19 is about one-tenths of patients in Jiangsu. Age, lymphocyte count, and pulmonary opacity in CT on admission were associated with risk of severe or critically ill COVID-19.
    • References:
      J Clin Invest. 2020 May 1;130(5):2620-2629. (PMID: 32217835)
      Diabetes Care. 2020 Jul;43(7):e72-e74. (PMID: 32409499)
      Ann Clin Microbiol Antimicrob. 2020 May 15;19(1):18. (PMID: 32414383)
      Clin Chim Acta. 2020 Jul;506:145-148. (PMID: 32178975)
      JAMA. 2020 Mar 3;:. (PMID: 32125362)
      Emerg Infect Dis. 2015 Nov;21(11):2029-35. (PMID: 26488195)
      BMJ. 2020 Feb 19;368:m606. (PMID: 32075786)
      J Clin Med. 2018 Aug 08;7(8):. (PMID: 30096809)
      Lancet Respir Med. 2020 Mar;8(3):e11-e12. (PMID: 32061335)
      Eur Radiol. 2020 Aug;30(8):4407-4416. (PMID: 32215691)
      Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. (PMID: 32064853)
      Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
      Obesity (Silver Spring). 2020 Jul;28(7):1195-1199. (PMID: 32271993)
      J Med Virol. 2020 Apr;92(4):441-447. (PMID: 31994742)
      Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143)
      N Engl J Med. 2020 May 21;382(21):2012-2022. (PMID: 32227758)
      Lancet Respir Med. 2020 May;8(5):475-481. (PMID: 32105632)
      Clin Immunol. 2020 May;214:108393. (PMID: 32222466)
      CMAJ. 2020 Jun 29;192(26):E694-E701. (PMID: 32461326)
      Br J Haematol. 2020 Jul;190(1):e24-e27. (PMID: 32420615)
      Blood. 2014 Jul 10;124(2):188-95. (PMID: 24876563)
      N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013)
      Ageing Res Rev. 2011 Jul;10(3):319-29. (PMID: 21145432)
      Commun Dis Intell (2018). 2020 Jun 5;44:. (PMID: 32517645)
      J Allergy Clin Immunol. 2020 Jul;146(1):110-118. (PMID: 32294485)
      Invest Radiol. 2020 Jun;55(6):327-331. (PMID: 32118615)
      Emerg Infect Dis. 2015 Nov;21(11):2088-90. (PMID: 26488869)
      Lancet Infect Dis. 2020 Apr;20(4):425-434. (PMID: 32105637)
      N Engl J Med. 2020 Jun 11;382(24):2372-2374. (PMID: 32302078)
      Viruses. 2020 Jan 24;12(2):. (PMID: 31991541)
      Biomark Med. 2020 Jun 3;:. (PMID: 32490680)
      Front Immunol. 2018 Apr 13;9:754. (PMID: 29706967)
      MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):382-386. (PMID: 32240123)
      JAMA. 2020 Feb 24;:. (PMID: 32091533)
      Trends Immunol. 2009 Jul;30(7):301-5. (PMID: 19541537)
      BMJ. 2020 May 22;369:m1966. (PMID: 32444366)
      Chin Med J (Engl). 2020 May 5;133(9):1087-1095. (PMID: 32358325)
      JAMA. 2020 Feb 7;:. (PMID: 32031570)
      JAMA. 2020 Apr 22;:. (PMID: 32320003)
      J Intern Med. 2020 Jul;288(1):128-138. (PMID: 32220033)
      Thorax. 2003 Aug;58(8):686-9. (PMID: 12885985)
      Ann Intensive Care. 2020 Mar 18;10(1):33. (PMID: 32189136)
      Chest. 2017 Dec;152(6):1151-1158. (PMID: 28823812)
      Int J Infect Dis. 2020 Apr;93:339-344. (PMID: 32198088)
      Lancet. 2020 Jun 6;395(10239):1763-1770. (PMID: 32442528)
      Atherosclerosis. 2001 Jun;156(2):451-6. (PMID: 11395043)
      J Infect. 2016 Nov;73(5):468-475. (PMID: 27519621)
    • Grant Information:
      81971885 National Natural Science Foundation of China; 81971888 National Natural Science Foundation of china; H2018048 the Scientific research project of Jiangsu Health Committee
    • Contributed Indexing:
      Keywords: COVID-19; Critically ill; Pneumonia; SARS-CoV-2; Severe; Severity
    • Publication Date:
      Date Created: 20200809 Date Completed: 20200811 Latest Revision: 20201218
    • Publication Date:
      20240105
    • Accession Number:
      PMC7407434
    • Accession Number:
      10.1186/s12879-020-05314-x
    • Accession Number:
      32762665